Growth Metrics

Balchem (BCPC) Asset Writedowns and Impairment (2016 - 2026)

Balchem (BCPC) has disclosed Asset Writedowns and Impairment for 16 consecutive years, with $289000.0 as the latest value for Q1 2026.

  • For Q1 2026, Asset Writedowns and Impairment rose 465.82% year-over-year to $289000.0; the TTM value through Mar 2026 reached $271000.0, up 9133.33%, while the annual FY2025 figure was -$97000.0, 132.44% down from the prior year.
  • Asset Writedowns and Impairment hit $289000.0 in Q1 2026 for Balchem, up from $21000.0 in the prior quarter.
  • Across five years, Asset Writedowns and Impairment topped out at $328000.0 in Q1 2022 and bottomed at -$132000.0 in Q3 2023.
  • Average Asset Writedowns and Impairment over 5 years is $54647.1, with a median of $31000.0 recorded in 2023.
  • Year-over-year, Asset Writedowns and Impairment tumbled 13100.0% in 2023 and then surged 619.35% in 2024.
  • Balchem's Asset Writedowns and Impairment stood at $22000.0 in 2022, then soared by 63.64% to $36000.0 in 2023, then surged by 69.44% to $61000.0 in 2024, then crashed by 65.57% to $21000.0 in 2025, then skyrocketed by 1276.19% to $289000.0 in 2026.
  • According to Business Quant data, Asset Writedowns and Impairment over the past three periods came in at $289000.0, $21000.0, and -$10000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.